Related references
Note: Only part of the references are listed.Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort
Henna Cederberg et al.
DIABETOLOGIA (2015)
Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue
Romain A. Colas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2014)
Fluvastatin Causes NLRP3 Inflammasome-Mediated Adipose Insulin Resistance
Brandyn D. Henriksbo et al.
DIABETES (2014)
Pro-resolving lipid mediators are leads for resolution physiology
Charles N. Serhan
NATURE (2014)
Multistate Point- Prevalence Survey of Health Care- Associated Infections
Shelley S. Magill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Lipid mediators in immune dysfunction after severe inflammation
James N. Fullerton et al.
TRENDS IN IMMUNOLOGY (2014)
Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment
James F. Markworth et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2013)
Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities
Ira Tabas et al.
SCIENCE (2013)
Novel n-3 Immunoresolvents: Structures and Actions
Jesmond Dalli et al.
SCIENTIFIC REPORTS (2013)
New approaches to the study of sepsis
Peter A. Ward
EMBO MOLECULAR MEDICINE (2012)
Rapid induction of inflammatory lipid mediators by the inflammasome in vivo
Jakob von Moltke et al.
NATURE (2012)
Infection regulates pro-resolving mediators that lower antibiotic requirements
Nan Chiang et al.
NATURE (2012)
Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation
Sungwhan F. Oh et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
ATORVASTATIN PREVENTS VASCULAR HYPOREACTIVITY TO NOREPINEPHRINE IN SEPSIS: ROLE OF NITRIC OXIDE AND α1-ADRENOCEPTOR mRNA EXPRESSION
Kathirvel Kandasamy et al.
SHOCK (2011)
Neutrophils cascading their way to inflammation
Christian D. Sadik et al.
TRENDS IN IMMUNOLOGY (2011)
Genetic Loci Associated with Plasma Phospholipid n-3 Fatty Acids: A Meta-Analysis of Genome-Wide Association Studies from the CHARGE Consortium
Rozenn N. Lemaitre et al.
PLOS GENETICS (2011)
Vane's blood-bathed organ technique adapted to examine the endothelial effects of cardiovascular drugs in vivo
Ryszard J. Gryglewski et al.
PHARMACOLOGICAL REPORTS (2010)
Activation of peroxisome proliferator-activated receptor-γ (PPAR-γ) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2
Yumei Ye et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2
S Atar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Physical exercise increases urinary excretion of lipoxin A4 and related compounds
S Gangemi et al.
JOURNAL OF APPLIED PHYSIOLOGY (2003)
Pharmacokineties of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients
RL Lins et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals
CN Serhan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Share Paper
